Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

CBC-Backed Hasten Biopharmaceutical Announces Acquisition of 14 Celltrion Legacy Products

Contributed by: PR Newswire

Tags

CBC-Group

More Like This

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

PR Newswire associated0

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

Business Wire logo

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates

Business Wire logo

Celltrion Announces the Acquisition of iQone Healthcare Switzerland, Further Building Its Expertise and Foothold in Europe

(Graphic: Business Wire)

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

Zymfentra® (Photo: Celltrion)

Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger

Business Wire logo

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us